Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam in Oromandibular and Cranial Dystonia
NCT02199509Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Jul 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levetiracetam in oromandibular dystonia (OMD), cranial dystonia, sponsored by National Institute of Neurological Disorders and Stroke. Started Jul 2014; status: completed.
02
Drugs
levetiracetam
03
Conditions
oromandibular dystonia (OMD)cranial dystonia
Beyond the preview
Go deeper on NCT02199509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02199509.